Results 101 to 110 of about 4,959 (174)

Dynamic transition of Tregs to cytotoxic phenotype amid systemic inflammation in Graves' ophthalmopathy. [PDF]

JCI Insight
Liu Z, Ke SR, Shi ZX, Zhou M, Sun L, Sun QH, Xiao B, Wang DL, Huang YJ, Lin JS, Wang HS, Zhang QK, Pan CN, Liang XW, Chen RX, Mao Z, Lin XC.   +16 more
europepmc   +1 more source

A Review of Pathophysiology and Therapeutic Strategies Targeting TGF-β in Graves' Ophthalmopathy. [PDF]

Cells
Chang HH, Wu SB, Tsai CC.
europepmc   +1 more source

Age and Clinical Activity Score (CAS): Key Predictive Factors for Non-shrinking Extraocular Muscles in Graves' Ophthalmopathy After Retrobulbar Injection of Glucocorticoids (GCs). [PDF]

Cureus
Xiang Y, Li R, Zhao G, Jiang F, Yang J.
europepmc   +1 more source

Graves ophthalmopathy a neglected comorbidity of graves' disease; a detailed investigation and management of sixty-eight patients in a tertiary healthcare center. [PDF]

BMC Endocr Disord
Akkus G, Ulaş B, Binokay H, Odabas F, Soysal RS, Özcan A, Sert M.   +6 more
europepmc   +1 more source

Comparison of orbital fibroblasts from Graves' ophthalmopathy and healthy control. [PDF]

Heliyon
Wu Y, Zhang J, Deng W, Mo C, Liang Y, Huang K, Xu F, Tang F.   +7 more
europepmc   +1 more source

Causal association between non-thyroidal autoimmune diseases and Graves' ophthalmopathy: A mendelian randomization study. [PDF]

Adv Ophthalmol Pract Res
Ma L, Jiang X, Hou Z, Li D.
europepmc   +1 more source

Selenium vs Control for Graves Ophthalmopathy in a Selenium-Sufficient Area: A Randomized Clinical Trial.

JAMA Ophthalmol
Ahn HY, Lee MJ, Jung KY, Kim HJ, Jung EH, Chung CW, Kim K, Jang J, Park YJ, Lee JK, Cho SW.   +10 more
europepmc   +1 more source

Deep learning methods for diagnosis of graves' ophthalmopathy using magnetic resonance imaging. [PDF]

Quant Imaging Med Surg
Ma ZC, Lin JY, Li SK, Liu HJ, Zhang YQ.
europepmc   +1 more source